Lurasidone is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Suppliers of lurasidone market it in the form of oral tablets. Alternatives to it are other antipsychotic medications such as perospirone, risperidone, paliperidone, and iloperidone.
The developer and earliest manufacturer of lurasidone medications was Sunovion Pharmaceuticals, which first introduced the drug into the market in 2010 under the trade name Latuda. It has since become approved in Canada and across the EU and has seen widespread use, with over 2 million prescriptions for it being registered annually in the U.S. alone.
Lurasidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lurasidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.